Literature DB >> 11251918

A large-scale evaluation of amnio-PCR for the rapid prenatal diagnosis of fetal trisomy.

L J Levett1, S Liddle, R Meredith.   

Abstract

OBJECTIVE: Traditional chromosome preparation from amniotic fluid samples often involves lengthy culture procedures in order to obtain cells for analysis. Multiplex quantitative fluorescent polymerase chain reaction (PCR) is a new molecular biological technique capable of quantifying in-situ DNA without the need for cell culture. Our objective was to test the reliability of PCR using fetal DNA from amniotic fluid (amnio-PCR) for the rapid prenatal diagnosis of the common trisomies.
DESIGN: This was a large prospective study of 5000 amniocentesis specimens. Multiplex quantitative fluorescent PCR was performed specifically for short tandem repeat sequences within chromosomes 21, 18, 13, X and Y. All amniocentesis samples were subsequently analyzed by traditional karyotyping methods.
RESULTS: Amnio-PCR detected all 89 major autosomal trisomies in this cohort. Diagnosis of sex chromosome anomalies was accurate for cases involving first meiotic division nondisjunction. However, further markers were necessary to detect sex chromosome anomalies arising from second meiotic division nondisjunction, highlighting the importance of using specific markers that enable the quantification of both the X and the Y chromosomes simultaneously.
CONCLUSIONS: Rapid prenatal diagnosis of trisomies 21, 18, and 13 and the sex chromosome anomalies using amnio-PCR is a reliable technique that aids the clinical management of pregnancy. The speed of the methodology will help to minimize the period of parental anxiety in the wait for a diagnostic test result.

Entities:  

Mesh:

Year:  2001        PMID: 11251918     DOI: 10.1046/j.1469-0705.2001.00340.x

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  7 in total

1.  Fetal nuchal translucency scan and early prenatal diagnosis of chromosomal abnormalities by rapid aneuploidy screening: observational study.

Authors:  Lyn S Chitty; Karl O Kagan; Francisca S Molina; Jonathan J Waters; Kypros H Nicolaides
Journal:  BMJ       Date:  2006-02-13

2.  The combined QF-PCR and cytogenetic approach in prenatal diagnosis.

Authors:  Akin Tekcan; Sengul Tural; Mehmet Elbistan; Nurten Kara; Davut Guven; Idris Kocak
Journal:  Mol Biol Rep       Date:  2014-07-31       Impact factor: 2.316

3.  A comparative analysis of the effectiveness of cytogenetic and molecular genetic methods in the detection of Down syndrome.

Authors:  Mirela Mačkić-Đurović; Petar Projić; Slavka Ibrulj; Jasmina Cakar; Damir Marjanović
Journal:  Bosn J Basic Med Sci       Date:  2014-05       Impact factor: 3.363

4.  Microfluidic digital PCR enables rapid prenatal diagnosis of fetal aneuploidy.

Authors:  H Christina Fan; Yair J Blumenfeld; Yasser Y El-Sayed; Jane Chueh; Stephen R Quake
Journal:  Am J Obstet Gynecol       Date:  2009-05       Impact factor: 8.661

5.  Quantitative fluorescent polymerase chain reaction for rapid prenatal diagnosis of fetal aneuploidies in chorionic villus sampling in a single institution.

Authors:  You Jung Shin; Jin Hoon Chung; Do Jin Kim; Hyun Mee Ryu; Moon Young Kim; Jung Yeol Han; June Seek Choi
Journal:  Obstet Gynecol Sci       Date:  2016-11-15

6.  Rapid prenatal diagnosis of Down Syndrome using quantitative fluorescent PCR in uncultured amniocytes.

Authors:  Moon-Hee Lee; Hyun-Mee Ryu; Do-Jin Kim; Bom-Yi Lee; Eun-Hee Cho; Jae-Hyug Yang; Moon-Young Kim; Jung-Yeol Han; So-Yeon Park
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

7.  Confined placental mosaicism: implications for fetal chromosomal analysis using microarray comparative genomic hybridization.

Authors:  Evangelia Karampetsou; Deborah Morrogh; Terry Ballard; Jonathan J Waters; Nicholas Lench; Lyn S Chitty
Journal:  Prenat Diagn       Date:  2013-11-14       Impact factor: 3.050

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.